Close Menu

integrated fluidic circuit

The company is also planning a new round of financing, and, with consent, banking its samples with the long-term goal of establishing an Indian biorepository.

NEW YORK (GenomeWeb) — Fluidigm said today that it has launched an early access program for its new SNP genotyping platform, the Juno system, for its key production genomics customers and prospects.

NEW YORK (GenomeWeb) — Fluidigm has launched a new architecture for its Dynamic Array integrated fluidic circuit (IFC) chips designed to provide users with maximum flexibility, time savings, and reduced waste for gene expression, genotyping, and single-cell gene expression studies.

This story was originally posted on Aug. 2.
Fluidigm last week raised its full-year 2013 guidance after posting 36 percent second-quarter revenue growth, largely due to increasing demand for its single-cell genomics products.

SINGAPORE — A new center located in this Asian city-state should expand regional single-cell biology research efforts and aid in the development of new diagnostics and therapies, according to its founders.

Fluidigm has placed three dozen of its C1 Single-Cell Auto Prep Systems since launching the instrument last year, and hopes to build on its momentum in the fledgling single-cell genomics market by expanding the number of applications that the C1 can support, as well as establishi

Fluidigm is launching four new consumable chips based on its integrated fluidic circuit technology, PCR Insider has learned.

This story was originally posted on April 20.

By Molika Ashford
Cleveland Clinic researchers have launched a 600-patient prospective study evaluating a SNP panel for predicting autism risk developed by French biotech firm IntegraGen.

Eisenberg Brothers will offer Fluidigm's complete portfolio of BioMark, EP1, and Access Array systems, as well as its line of integrated fluidic circuits.

Pages

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.

Michael Caputo, the top Department of Health and Human Service spokesperson, is taking a leave of absence, CNN says.

CNBC reports that the CDC Director says a SARS-CoV-2 vaccine isn't likely to be generally available until the third quarter of 2021, timing President Donald Trump disputes.

In Nature this week: MassIVE.quant resource houses mass spectrometry-based proteomic data, influence of Viking genetics on European populations, and more.